Altay, Ozlem

Machine learning identifies proteomic risk factors across 23 diseases

A human pan-disease blood atlas of the circulating proteome

Targeting PKLR in liver diseases

Unravelling the Complexity of Sarcopenia Through a Systems Biology Approach

Integrative proteo-transcriptomic characterization of advanced fibrosis in chronic liver disease across etiologies

Multi-omics characterization of improved cognitive functions in Parkinson's disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial

Identifying Hub Genes and Metabolic Pathways in Collagen VI-Related Dystrophies: A Roadmap to Therapeutic Intervention

Multi-omics analysis reveals the key factors involved in the severity of the Alzheimer's disease

Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases (Retraction of Vol 314, art no 121325, 2023)

Combined Metabolic Activators with Different NAD+ Precursors Improve Metabolic Functions in the Animal Models of Neurodegenerative Diseases

Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases

Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial

Multiomics Analysis Reveals the Impact of Microbiota on Host Metabolism in Hepatic Steatosis

Systems Biology Approaches to Decipher the Underlying Molecular Mechanisms of Glioblastoma Multiforme

Revealing the Molecular Mechanisms of Alzheimer's Disease Based on Network Analysis

Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19

Addressing the heterogeneity in liver diseases using biological networks

Revealing the Metabolic Alterations during Biofilm Development of <i>Burkholderia cenocepacia</i> Based on Genome-Scale Metabolic Modeling